Overview

  • Product name

    Idazoxan hydrochloride, alpha2 Adrenoceptor antagonist and I2 ligand
  • Description

    α2 Adrenoceptor antagonist and I2 ligand
  • Biological description

    α2 Adrenoceptor antagonist and I2 ligand. Improves motor symptoms and decreases dyskinesia in Parkinson's disease models. Also induces apoptosis. Active in vivo.
  • Purity

    > 99%
  • CAS Number

    79944-56-2
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Eilon GF  et al. Antineoplastic activity of idazoxan hydrochloride. Cancer Chemother Pharmacol 64:1157-63 (2009). Read more (PubMed: 19308411) »
  • Invernizzi RW  et al. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms. Neuropsychopharmacology 28:872-9 (2003). Read more (PubMed: 12644843) »
  • Henry B  et al. The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease. Mov Disord 14:744-53 (1999). Read more (PubMed: 10495035) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141130.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up